文献速递头颈CT

增强CT影像组学预测头颈鳞癌乳酸代谢分型及预后

Development and validation of a radiomics model for lactate metabolism genes-based stratification and prognostic prediction in head and neck squamous cell carcinoma.
PubMed 文献 · Eur J Radiol · 2026-01-17

基于TCGA和TCIA数据库399例头颈鳞癌患者,从增强CT提取2060个影像组学特征,结合乳酸代谢基因相关特征构建SVM模型预测乳酸分型评分。训练集AUC为0.773,验证集AUC为0.760。高影像组学评分与较差总生存相关(HR=3.582,95%CI:1.240-10.348,P=0.018)。

要点

  • 高影像组学评分提示乳酸代谢高危分型,总生存较差
  • 高影像组学评分与神经周围侵犯和切缘状态相关
  • 增强CT影像组学可无创预测乳酸代谢分型,辅助预后判断

核心结论

  • 增强CT影像组学模型可有效预测头颈鳞癌乳酸代谢相关分型,具有预后评估价值

研究设计与样本

  • 回顾性研究,利用TCGA和TCIA数据库,纳入399例头颈鳞癌患者
  • 分析204个乳酸相关基因,识别出24个差异表达的乳酸代谢基因相关基因
  • 从增强CT图像提取2060个影像组学特征,经mRMR和RFE特征选择后构建支持向量机模型

关键影像表现/征象

  • 高影像组学评分组在增强CT上无直接描述的具体影像征象,原文未报告对应影像形态学特征

诊断标准与关键数值

  • 乳酸分型评分在单因素评估中与总生存相关(HR=1.807,95%CI:1.346-2.424,P<0.001)
  • 乳酸分型评分在多因素评估中与总生存相关(HR=1.772,95%CI:1.296-2.424,P<0.001)
  • 影像组学模型预测乳酸分型评分的AUC在训练集为0.773,验证集为0.760
  • 高影像组学评分与较差总生存相关(HR=3.582,95%CI:1.240-10.348,P=0.018)
  • 训练集中不同乳酸亚型间影像组学评分分布差异有统计学意义(P<0.001)

临床应用与阅片要点

  • 高影像组学评分可提示头颈鳞癌患者乳酸代谢高危状态,需关注不良预后风险
  • 影像组学评分与神经周围侵犯和切缘状态相关,可作为术前无创评估补充信息
  • 高影像组学评分组富集免疫抑制微环境,可能对免疫治疗选择有一定提示意义

局限性

  • 研究基于TCGA和TCIA公共数据库,属于回顾性设计
  • 原文未报告外部独立验证队列,验证集AUC为0.760显示泛化效能有限

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Head and neck squamous cell carcinoma (HNSCC) is a highly heterogeneous malignancy characterized by altered lactate metabolism, where traditional prognostic indicators are insufficient for precision medicine. This study aimed to construct an enhanced CT radiomics model integrated with lactate metabolism gene-related (LMGR) genomic signatures for HNSCC prognosis using TCGA and TCIA databases. A cohort of 399 HNSCC patients was analyzed. Analysis of 204 lactate-related genes identified 24 differentially expressed LMGR genes (DELMGR). Univariate Cox regression revealed that among these, PKLR, IL19, and CXCL9 exhibited protective effects (HR = 0.932, 0.885, and 0.931, respectively). A lactate classification score (LCS) was derived from the analysis of these three genes, demonstrating a significant correlation with overall survival (OS) in both univariate (HR = 1.807, 95 % CI: 1.346-2.424, P < 0.001) and multivariate assessments (HR = 1.772, 95 % CI: 1.296-2.424, P < 0.001). From enhanced CT images, 2060 radiomic features were extracted. Subsequently, after feature selection using mRMR and RFE algorithms, a support vector machine (SVM) model was built to predict LCS, which generated a radiomics score (RS). The model demonstrated AUC values of 0.773 and 0.760 in the training and validation datasets, respectively. The RS distribution significantly differed between lactate subtypes in the training cohort (P < 0.001), with specifically higher RS in the high-risk LCS group. High RS was associated with poor OS (HR = 3.582, 95 % CI: 1.240-10.348, P = 0.018) and was correlated with clinical features such as the perineural invasion and the margin status. Mechanistic analysis indicated that the high RS group was enriched in an immunosuppressive microenvironment and was associated with fatty acid metabolism pathways. This enhanced CT-based radiomics model effectively predicts lactate-based stratification, demonstrating potential prognostic value in HNSCC and providing novel biomarkers as well as a non-invasive predictive tool for prognostic assessment.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Yuan, Yuan, Chen, et al. Development and validation of a radiomics model for lactate metabolism genes-based stratification and prognostic prediction in head and neck squamous cell carcinoma. Eur J Radiol. 2026. PMID: 41579670. doi:10.1016/j.ejrad.2026.112666

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。